While prophylactic vaccination is likely to provide important future health gains, cervical cancer screening will need to be continued for the whole generation of women that is already infected with the HPV types included in vaccines. Potential reductions in cervical cancer screening due to misconceptions about HPV vaccine protection or any relaxation of cervical cancer screening could result in an increase in cervical cancer rather than the anticipated reductions. Many alterations in cervical cancer screening are anticipated and needed in the near term and over the long-term, population-based U.S. surveillance is critical to assessing the safety and effectiveness of these changes as well as to address continuing failures In the cervical screening, diagnosis and treatment process. Sustained population-based surveillance enables the assessment of system and practice failures and successes prior to and coincident with a variety of anticipated overlapping changes in cervical cancer prevention programs (e.g. vaccination, lengthened screening Intervals and new HPV tests and applications). In anticipation of the critical need for population-based, woman-based surveillance of U.S. cervical cancer screening, the New Mexico Notifiable Diseases and Conditions (NMAC incorporated mandatory state-wide reporting of all cervical screening (Pap and HPV) and all diagnostic and treatment procedures (cervical, vulvar and vaginal pathology), whether positive or negative or abnormal or normal, respectively. Our innovative surveillance transcends organizations and systems of care enabling the NM-HOPES-PRC Research Project 2 to conduct a comprehensive population-based elaboration of cervical cancer screening processes and its deficiencies (failures) with the goal of enabling future interventions that improve cervical cancer prevention. Data from our cervical cancer screening surveillance unit, the New Mexico HPV Pap Registry (NMHPVPR) will also be linked to the New Mexico Tumor Registry (NMTR) to describe screening, diagnosis and treatment histories of women diagnosed with incident invasive cerviical cancer. The NMTR is a founding member of the U.S. National Cancer Institute's Sun/eillance, Epidemiology, and End Results (SEER) Program. Through partnerships with the University of New Mexico (UNM) Geospatial and Population Studies (GPS) program and the University of Southern California's (USC) GIS Research Lab, we will identify and evaluate the impact of geographic barriers on failures in screening and prevention practices and invasive cervical cancer outcomes. New Mexico offers a rich opportunity in which this surveillance is conducted among diverse multi-cultural populations suffering a variety of health disparities including those attributable to high levels of poverty and rural living.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of New Mexico Health Sciences Center
United States
Zip Code
McCarthy, Anne Marie; Kim, Jane J; Beaber, Elisabeth F et al. (2016) Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. Am J Prev Med 51:507-12
Kim, Jane J; Tosteson, Anna Na; Zauber, Ann G et al. (2016) Cancer Models and Real-world Data: Better Together. J Natl Cancer Inst 108:
Tosteson, Anna N A; Beaber, Elisabeth F; Tiro, Jasmin et al. (2016) Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med 31:372-9
Haas, Jennifer S; Sprague, Brian L; Klabunde, Carrie N et al. (2016) Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med 31:52-9
McDonald, Yolanda J; Goldberg, Daniel W; Scarinci, Isabel C et al. (2016) Health Service Accessibility and Risk in Cervical Cancer Prevention: Comparing Rural Versus Nonrural Residence in New Mexico. J Rural Health :
Gage, Julia C; Hunt, William C; Schiffman, Mark et al. (2016) Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program. Cancer Epidemiol Biomarkers Prev 25:36-42
Corley, Douglas A; Haas, Jennifer S; Kobrin, Sarah (2016) Reducing Variation in the ""Standard of Care"" for Cancer Screening: Recommendations From the PROSPR Consortium. JAMA 315:2067-8
Gage, Julia C; Hunt, William C; Schiffman, Mark et al. (2016) Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstet Gynecol :
Kim, Jane J; Campos, Nicole G; Sy, Stephen et al. (2015) Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Ann Intern Med 163:589-97
Cuzick, Jack; Myers, Orrin; Hunt, William C et al. (2015) Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management. Int J Cancer 136:2854-63

Showing the most recent 10 out of 24 publications